Oneness Biotech Co., Ltd.

Brand Name	FESPIXON^® Cream
Indications	Diabetic Foot Ulcers (DFU)
Mechanism of Action	Inhibits inflammation Regulates the generation of collagen Promotes the regeneration of damaged cells Promotes the proliferation of human keratinocytes Reduce inflammatory M1 macrophages, stimulate adipose precursor cells to secrete GCSF and CXCL3, and increase repairing M2a/M2c macrophages, thereby promote complete wound healing. The mechanism of action studies can be referred to JID Innovations (2022).
Taiwan FDA Approval Number	060827
Singapore HSA Approval Number	SIN16683P
Malaysia NPRA Approval Number	MAL23076025B
China NMPA Approval Number	ZC20230001 (Approved generic name: Xianglei Tangzu Gao)
Indonesia BPOM Approval Number	TI247049901
Research Publication/ Abstract	More Infromation

You are encouraged to report negative side effects of prescription drugs to:
Phone: 0800-258-688
Mail: PV.PMS@onenessbio.com.tw

Prescription medications must be used only under the direction of a licensed physician. If you have any health concerns, please seek medical advice from a qualified healthcare provider. Find the closest hospital for medical care.

Package Insert Download

Brand Name

FESPIXON^® Cream

Indications

Diabetic Foot Ulcers (DFU)

Mechanism of Action

Inhibits inflammation
Regulates the generation of collagen
Promotes the regeneration of damaged cells
Promotes the proliferation of human keratinocytes
Reduce inflammatory M1 macrophages, stimulate adipose precursor cells to secrete GCSF and CXCL3, and increase repairing M2a/M2c macrophages, thereby promote complete wound healing. The mechanism of action studies can be referred to JID Innovations (2022).